Clinical Trial Update: Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating oxaliplatin, gefitinib, and radiation therapy for locally advanced or metastatic esophageal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Iressa (gefitinib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: TERMINATED